Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Thalidomide may stop the growth of ovarian cancer by stopping blood
flow to the tumor.
PURPOSE: This randomized phase II trial is studying how well giving carboplatin together with
thalidomide works compared to carboplatin alone in treating patients with ovarian epithelial
cancer.